Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Provectus Biopharmaceuticals Inc (NYSE MKT LLC:PVCT)

0.3609
Delayed Data
As of May 27
 +0.0109 / +3.11%
Today’s Change
0.32
Today|||52-Week Range
0.84
-7.46%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$83.0M

Company Description

Provectus Biopharmaceuticals, Inc. engages in the development of pharmaceuticals for oncology and dermatology indications. Its products include PV-10 and PH-10. The company was founded on January 17, 2002 and is headquartered in Knoxville, TN.

Contact Information

Provectus Biopharmaceuticals, Inc.
7327 Oak Ridge Highway
Knoxville Tennessee 37931
P:(866) 594-5999
Investor Relations:

Employees

Shareholders

Individual stakeholders6.28%
Mutual fund holders2.24%
Other institutional2.18%

Top Executives

Peter R. CulpepperCEO, Chief Operating & Accounting Officer
Timothy C. ScottPresident & Director
John R. GlassChief Financial Officer
Eric A. WachterChief Technology Officer & Director